Engineered nanomicelles inhibit the tumour progression via abrogating the prostaglandin-mediated immunosuppression.
Yadav P, Rana K, Nardini V, Khan A, Pani T, Kar A, Jain D, Chakraborty R, Singh R, Jha SK, Mehta D, Sharma H, Sharma RD, Deo SVS, Sengupta S, Patil VS, Faccioli LH, Dasgupta U, Bajaj A.
Yadav P, et al. Among authors: bajaj a.
J Control Release. 2024 Apr;368:548-565. doi: 10.1016/j.jconrel.2024.03.009. Epub 2024 Mar 13.
J Control Release. 2024.
PMID: 38462044